MEETING CANCELLED: Drug Development in the Digital Age

joint with MEETING CANCELLED: Digital Paths to Improve Human Health

Organizer(s): Chris Benko and Qi Liu

Supported by the Directors' Fund

Summary of Meeting:

For more information on the virtual eSymposia format Click here

In this digital age, access to copious amounts of rapidly amassed data is made possible by innovative techniques like machine learning (ML) and artificial intelligence (AI) algorithms. While this provides new opportunities for drug development and precision medicine, it also reveals ethical issues surrounding privacy and data sharing. Interpreting data demonstrates an additional challenge. Data must be presented in the patient’s terms and requires a well-defined patient context to be relevant. The goal of this meeting is to discuss emerging technology and the opportunities it provides. Promising uses for AI/ML include drug discovery or repurposing, analyzing data from imaging and genomics and using digital biomarkers. Developing new drugs and techniques for precision medicine can be done with real-world data and decentralized trials. This meeting will draw interest from many fields and attendees will have the opportunity to consider challenges and potential solutions in data sharing, ethical considerations and patient relevance. The joint meeting, Digital Paths to Improve Human Health, will feature complimentary themes.

We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations

Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations